SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016183
Filing Date
2023-05-10
Accepted
2023-05-10 16:35:02
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 949033
2 ex10-5.htm EX-10.5 17424
3 ex31-1.htm EX-31.1 22472
4 ex31-2.htm EX-31.2 21148
5 ex32-1.htm EX-32.1 8334
6 ex32-2.htm EX-32.2 8189
  Complete submission text file 0001493152-23-016183.txt   4431291

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cing-20230331.xsd EX-101.SCH 28776
8 XBRL CALCULATION FILE cing-20230331_cal.xml EX-101.CAL 53960
9 XBRL DEFINITION FILE cing-20230331_def.xml EX-101.DEF 120417
10 XBRL LABEL FILE cing-20230331_lab.xml EX-101.LAB 246581
11 XBRL PRESENTATION FILE cing-20230331_pre.xml EX-101.PRE 200138
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 684156
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40874 | Film No.: 23907104
SIC: 2834 Pharmaceutical Preparations